• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沉默调节蛋白1/沉默调节蛋白3是强大的赖氨酸去乳酰化酶,且沉默调节蛋白1介导的去乳酰化作用调节糖酵解。

Sirtuin 1/sirtuin 3 are robust lysine delactylases and sirtuin 1-mediated delactylation regulates glycolysis.

作者信息

Du Runhua, Gao Yanmei, Yan Cong, Ren Xuelian, Qi Shankang, Liu Guobin, Guo Xinlong, Song Xiaohan, Wang Hanmin, Rao Jingxin, Zang Yi, Zheng Mingyue, Li Jia, Huang He

机构信息

School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.

State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.

出版信息

iScience. 2024 Sep 10;27(10):110911. doi: 10.1016/j.isci.2024.110911. eCollection 2024 Oct 18.

DOI:10.1016/j.isci.2024.110911
PMID:39351192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11440250/
Abstract

Lysine lactylation (Kla), an epigenetic mark triggered by lactate during glycolysis, including the Warburg effect, bridges metabolism and gene regulation. Enzymes such as p300 and HDAC1/3 have been pivotal in deciphering the regulatory dynamics of Kla, though questions about additional regulatory enzymes, their specific Kla substrates, and the underlying functional mechanisms persist. Here, we identify SIRT1 and SIRT3 as key "erasers" of Kla, shedding light on their selective regulation of both histone and non-histone proteins. Proteomic analysis in SIRT1/SIRT3 knockout HepG2 cells reveals distinct substrate specificities toward Kla, highlighting their unique roles in cellular signaling. Notably, we highlight the role of specific Kla modifications, such as those on the M2 splice isoform of pyruvate kinase (PKM2), in modulating metabolic pathways and cell proliferation, thereby expanding Kla's recognized functions beyond epigenetics. Therefore, this study deepens our understanding of Kla's functional mechanisms and broadens its biological significance.

摘要

赖氨酸乳酰化(Kla)是糖酵解过程中由乳酸触发的一种表观遗传标记,包括瓦伯格效应,它在代谢和基因调控之间架起了桥梁。诸如p300和HDAC1/3等酶在解读Kla的调控动态方面起着关键作用,不过关于其他调控酶、它们特定的Kla底物以及潜在的功能机制等问题依然存在。在此,我们确定SIRT1和SIRT3是Kla的关键“擦除器”,揭示了它们对组蛋白和非组蛋白的选择性调控。对SIRT1/SIRT3基因敲除的HepG2细胞进行的蛋白质组分析揭示了对Kla的不同底物特异性,突出了它们在细胞信号传导中的独特作用。值得注意的是,我们强调了特定的Kla修饰的作用,比如丙酮酸激酶(PKM2)的M2剪接异构体上的修饰,在调节代谢途径和细胞增殖方面的作用,从而将Kla公认的功能扩展到表观遗传学之外。因此,本研究加深了我们对Kla功能机制的理解,并拓宽了其生物学意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220b/11440250/9edb61f63bdd/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220b/11440250/3d7196967ec1/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220b/11440250/d06d6e01d6f7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220b/11440250/8eee67694842/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220b/11440250/987cb85e4d46/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220b/11440250/a36991806adf/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220b/11440250/1abc38317496/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220b/11440250/18f112137a34/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220b/11440250/9edb61f63bdd/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220b/11440250/3d7196967ec1/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220b/11440250/d06d6e01d6f7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220b/11440250/8eee67694842/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220b/11440250/987cb85e4d46/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220b/11440250/a36991806adf/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220b/11440250/1abc38317496/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220b/11440250/18f112137a34/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220b/11440250/9edb61f63bdd/gr7.jpg

相似文献

1
Sirtuin 1/sirtuin 3 are robust lysine delactylases and sirtuin 1-mediated delactylation regulates glycolysis.沉默调节蛋白1/沉默调节蛋白3是强大的赖氨酸去乳酰化酶,且沉默调节蛋白1介导的去乳酰化作用调节糖酵解。
iScience. 2024 Sep 10;27(10):110911. doi: 10.1016/j.isci.2024.110911. eCollection 2024 Oct 18.
2
Identification of SIRT3 as an eraser of H4K16la.鉴定SIRT3作为H4K16la的去乙酰化酶
iScience. 2023 Aug 28;26(10):107757. doi: 10.1016/j.isci.2023.107757. eCollection 2023 Oct 20.
3
Chiral Posttranslational Modification to Lysine ε-Amino Groups.手性赖氨酸 ε-氨基的翻译后修饰
Acc Chem Res. 2022 May 17;55(10):1456-1466. doi: 10.1021/acs.accounts.2c00115. Epub 2022 May 2.
4
SIRT3-dependent delactylation of cyclin E2 prevents hepatocellular carcinoma growth.SIRT3 依赖性去酰化 cyclin E2 可预防肝细胞癌生长。
EMBO Rep. 2023 May 4;24(5):e56052. doi: 10.15252/embr.202256052. Epub 2023 Mar 10.
5
Class I histone deacetylases (HDAC1-3) are histone lysine delactylases.I类组蛋白去乙酰化酶(HDAC1 - 3)是组蛋白赖氨酸去乙酰基酶。
Sci Adv. 2022 Jan 21;8(3):eabi6696. doi: 10.1126/sciadv.abi6696. Epub 2022 Jan 19.
6
Ubiquitous protein lactylation in health and diseases.健康与疾病中的普遍存在的蛋白质乳酰化
Cell Mol Biol Lett. 2024 Feb 5;29(1):23. doi: 10.1186/s11658-024-00541-5.
7
Comprehensive review of histone lactylation: Structure, function, and therapeutic targets.组蛋白乳酰化的综合综述:结构、功能和治疗靶点。
Biochem Pharmacol. 2024 Jul;225:116331. doi: 10.1016/j.bcp.2024.116331. Epub 2024 May 29.
8
YiaC and CobB regulate lysine lactylation in Escherichia coli.YiaC 和 CobB 调节大肠杆菌赖氨酸内酯化。
Nat Commun. 2022 Nov 4;13(1):6628. doi: 10.1038/s41467-022-34399-y.
9
Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma.乳酰化组分析提示肝细胞癌中存在依赖乳酰化的代谢适应机制。
Nat Metab. 2023 Jan;5(1):61-79. doi: 10.1038/s42255-022-00710-w. Epub 2023 Jan 2.
10
HBO1 catalyzes lysine lactylation and mediates histone H3K9la to regulate gene transcription.HBO1 催化赖氨酸乳酰化作用,并介导组蛋白 H3K9la 来调节基因转录。
Nat Commun. 2024 Apr 26;15(1):3561. doi: 10.1038/s41467-024-47900-6.

引用本文的文献

1
Protein lactylation in kidney diseases.肾脏疾病中的蛋白质乳酰化
Front Cell Dev Biol. 2025 Aug 13;13:1533175. doi: 10.3389/fcell.2025.1533175. eCollection 2025.
2
Targeting Lactylation: From Metabolic Reprogramming to Precision Therapeutics in Liver Diseases.靶向乳酰化:从代谢重编程到肝脏疾病的精准治疗
Biomolecules. 2025 Aug 16;15(8):1178. doi: 10.3390/biom15081178.
3
H4K79 and H4K91 histone lactylation, newly identified lactylation sites enriched in breast cancer.H4K79和H4K91组蛋白乳酰化,新发现的在乳腺癌中富集的乳酰化位点。

本文引用的文献

1
SIRT3: A potential therapeutic target for liver fibrosis.SIRT3:肝纤维化的潜在治疗靶点。
Pharmacol Ther. 2024 May;257:108639. doi: 10.1016/j.pharmthera.2024.108639. Epub 2024 Mar 30.
2
Metabolic regulation of homologous recombination repair by MRE11 lactylation.MRE11 乳糖酰化对同源重组修复的代谢调控。
Cell. 2024 Jan 18;187(2):294-311.e21. doi: 10.1016/j.cell.2023.11.022. Epub 2023 Dec 20.
3
SIRT3 regulates mitochondrial function: A promising star target for cardiovascular disease therapy.SIRT3 调节线粒体功能:心血管疾病治疗有前途的明星靶点。
J Exp Clin Cancer Res. 2025 Aug 23;44(1):252. doi: 10.1186/s13046-025-03512-6.
4
Biochemistry and regulation of histone lysine L-lactylation.组蛋白赖氨酸L-乳酰化的生物化学与调控
Nat Rev Mol Cell Biol. 2025 Aug 19. doi: 10.1038/s41580-025-00876-7.
5
Lactylation of Mitochondrial Adenosine Triphosphate Synthase Subunit Alpha Regulates Vascular Remodeling and Progression of Aortic Dissection.线粒体三磷酸腺苷合酶α亚基的乳酰化修饰调控血管重塑及主动脉夹层进展。
Research (Wash D C). 2025 Aug 12;8:0799. doi: 10.34133/research.0799. eCollection 2025.
6
SIRT3 mediates CPT2 delactylation to enhance mitochondrial function and proliferation in goat granulosa cells.SIRT3介导CPT2去乙酰化以增强山羊颗粒细胞的线粒体功能和增殖。
J Anim Sci Biotechnol. 2025 Jul 17;16(1):101. doi: 10.1186/s40104-025-01231-8.
7
Navigating the role of protein lactylation in prostate cancer and its implications for immunotherapy.探索蛋白质乳酰化在前列腺癌中的作用及其对免疫治疗的影响。
J Cancer. 2025 Jun 12;16(8):2706-2719. doi: 10.7150/jca.114137. eCollection 2025.
8
Lactylation: the regulatory code of cellular life activity and a barometer of diseases.乳酰化:细胞生命活动的调控密码与疾病晴雨表
Cell Oncol (Dordr). 2025 Jun 16. doi: 10.1007/s13402-025-01083-4.
9
The lactylation-immune regulatory axis: a potential therapeutic target for migraine prevention and treatment.乳酰化-免疫调节轴:偏头痛防治的潜在治疗靶点。
J Headache Pain. 2025 Jun 4;26(1):134. doi: 10.1186/s10194-025-02075-3.
10
Lactate and lactylation in liver diseases: energy metabolism, inflammatory immunity and tumor microenvironment.肝脏疾病中的乳酸与乳酸化:能量代谢、炎症免疫与肿瘤微环境
Front Immunol. 2025 May 12;16:1581582. doi: 10.3389/fimmu.2025.1581582. eCollection 2025.
Biomed Pharmacother. 2024 Jan;170:116004. doi: 10.1016/j.biopha.2023.116004. Epub 2023 Dec 11.
4
SIRT1/SREBPs-mediated regulation of lipid metabolism.SIRT1/SREBPs 介导的脂质代谢调节。
Pharmacol Res. 2024 Jan;199:107037. doi: 10.1016/j.phrs.2023.107037. Epub 2023 Dec 7.
5
Current Advances on Nanomaterials Interfering with Lactate Metabolism for Tumor Therapy.纳米材料干扰乳酸代谢在肿瘤治疗中的最新进展。
Adv Sci (Weinh). 2024 Jan;11(3):e2305662. doi: 10.1002/advs.202305662. Epub 2023 Nov 8.
6
SIRT1 is a regulator of autophagy: Implications for the progression and treatment of myocardial ischemia-reperfusion.SIRT1 是自噬的调节因子:对心肌缺血再灌注进展和治疗的影响。
Pharmacol Res. 2024 Jan;199:106957. doi: 10.1016/j.phrs.2023.106957. Epub 2023 Oct 10.
7
Identification of SIRT3 as an eraser of H4K16la.鉴定SIRT3作为H4K16la的去乙酰化酶
iScience. 2023 Aug 28;26(10):107757. doi: 10.1016/j.isci.2023.107757. eCollection 2023 Oct 20.
8
SIRT3-dependent delactylation of cyclin E2 prevents hepatocellular carcinoma growth.SIRT3 依赖性去酰化 cyclin E2 可预防肝细胞癌生长。
EMBO Rep. 2023 May 4;24(5):e56052. doi: 10.15252/embr.202256052. Epub 2023 Mar 10.
9
Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma.乳酰化组分析提示肝细胞癌中存在依赖乳酰化的代谢适应机制。
Nat Metab. 2023 Jan;5(1):61-79. doi: 10.1038/s42255-022-00710-w. Epub 2023 Jan 2.
10
The sirtuin family in health and disease.长寿蛋白家族与健康和疾病。
Signal Transduct Target Ther. 2022 Dec 29;7(1):402. doi: 10.1038/s41392-022-01257-8.